o(6)-benzylguanine has been researched along with B16 Melanoma in 3 studies
O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity
| Excerpt | Relevance | Reference |
|---|---|---|
| ") was examined using single and daily x5 dosing regimens in athymic mice bearing subcutaneous A375P xenografts." | 1.30 | Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. ( Newlands, ES; Porteous, JK; Wedge, SR, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wedge, SR | 1 |
| Porteous, JK | 1 |
| Newlands, ES | 1 |
| Humbert, O | 1 |
| Fiumicino, S | 1 |
| Aquilina, G | 1 |
| Branch, P | 1 |
| Oda, S | 1 |
| Zijno, A | 1 |
| Karran, P | 1 |
| Bignami, M | 1 |
| Maze, R | 1 |
| Kurpad, C | 1 |
| Pegg, AE | 1 |
| Erickson, LC | 1 |
| Williams, DA | 1 |
3 other studies available for o(6)-benzylguanine and B16 Melanoma
| Article | Year |
|---|---|
Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother | 1997 |
Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
Topics: 3T3 Cells; Alkylating Agents; Animals; Antineoplastic Agents; Apoptosis; Base Pair Mismatch; Chromos | 1999 |
Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
Topics: Animals; Antineoplastic Agents; Carcinoma; Ethylnitrosourea; Female; Genetic Vectors; Guanine; Hemat | 1999 |